VCA Specialty Update Symposium

SUNDAY 13 SEPTEMBER
09:00 – 12:50     VCA Specialty Update Symposium

CHAIRS:   Lionel Badet, Lyon, France
                 Emmanuel Morelon, Paris, France           

09:00     Limitations and results of face transplantation
             Sylvie Testelin, Amiens, France

09:30     Limitations and results of upper limb transplantation
             Stefan Schneeberger, Innsbruck, Austria

10:00     Laryngeal and Tracheal transplantation
             Pierre Delaere, Leuven, Belgium

10:40 – 11:10    Coffee Break

SESSION 2: Joint Session Basic Science & Vascularized Composite Allotransplantation

CHAIRS:  Pietro Cippà, Zurich, Switzerland
                Henri Leuvenink, Groningen, The Netherlands

11:10     Chronic rejection in VCA: from myth to reality
             Olivier Thaunat, Lyon, France

11:40    Cell-based therapy options in VCA
             Jan Plock, Zurich, Switzerland

12:10     What have we learned from animal models in VCA?  
             Gerald Brandacher, Baltimore, United States  

_________________________________________________________________________________________________________________________

VCA in pills:
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This committee brings together 10 representatives of major European teams at the forefront in this field.

Goals:
Our goal is to raise the scientific and clinical development of Vascularized Composite Allotransplantation (VCA) in Europe and to serve as a platform for scientists and clinicians for information and exchange.

Objectives:

• Understand the risks and limits of face and upper limb transplantation
• Discuss and implement new data to characterize chronic rejection
• Discuss the contribution of animal models in VCA
• Discuss alternatives strategies  for patients’ management

Target audience:
Surgeons, physicians, researchers, transplant coordinators